-
How Advances in Genetics and Genomics are Reimagining Cancer Patient Care
Drs. Corrie Painter and Eliezer Van Allen discuss how advances in genetics and genomics are impacting clinical…
-
Exploring the Potential of Natural Killer Cells with Dr. Oscar Aguilar
CRI postdoctoral fellow Dr. Oscar Aguilar is exploring the biology of Natural Killer cells in order to…
-
The Microbiome and Cancer-on-a-Chip with Dr. Hyun Jung Kim
CRI Tech Impact grantee Dr. Hyun Jung Kim is building a colorectal-cancer-on-a-chip device to better understand how…
-
Recapping ASCO20: The Next Horizons in Immunotherapy
The 56th Annual ASCO Meeting highlighted advances in checkpoint immunotherapy, cell-based immunotherapies, and bispecific antibodies.
-
ASCO20 Update: Considerations for Checkpoint Inhibitors Moving Forward
Results unveiled at ASCO20 increased our understanding of checkpoint immunotherapy in a variety of cancers and circumstances.
-
ASCO20 Update: Cellular Immunotherapies, Genomics, and COVID-19
Several promising cellular immunotherapies were discussed at ASCO20, including those for solid cancers; plus updates on the cancer…
-
Investigating the Innate Immune Receptor NLRP6 with Dr. Chen Shen
CRI Fellow Dr. Chen Shen is investigating NLRP6, a receptor that can recognize bacteria or viruses and…
-
Building a Single-Cell Atlas with Dr. Ansuman Satpathy
Dr. Ansuman Satpathy is building a single-cell atlas to help us better understand why immunotherapy succeeds or…
-
ASCO20 Preview: Unite & Conquer – Accelerating Progress Together
The ASCO20 Annual Meeting kicks off virtually on Friday, May 31—and advances in immunotherapy will be a…
